Intervention Review

You have free access to this content

Antiplatelet agents for chronic kidney disease

  1. Suetonia C Palmer1,*,
  2. Lucia Di Micco2,
  3. Mona Razavian3,
  4. Jonathan C Craig4,5,
  5. Vlado Perkovic3,
  6. Fabio Pellegrini6,7,
  7. Meg J Jardine8,
  8. Angela C Webster4,5,9,
  9. Sophia Zoungas10,
  10. Giovanni FM Strippoli4,5,11,12,13

Editorial Group: Cochrane Renal Group

Published Online: 30 APR 2013

Assessed as up-to-date: 24 JAN 2011

DOI: 10.1002/14651858.CD008834.pub3


How to Cite

Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Pellegrini F, Jardine MJ, Webster AC, Zoungas S, Strippoli GFM. Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD008834. DOI: 10.1002/14651858.CD008834.pub3.

Author Information

  1. 1

    University of Otago Christchurch, Department of Medicine, Christchurch, New Zealand

  2. 2

    University of Naples "Federico II", Division of Nephrology, Naples, Italy

  3. 3

    The George Institute for Global Health, Renal and Metabolic Division, Camperdown, NSW, Australia

  4. 4

    The University of Sydney, Sydney School of Public Health, Sydney, NSW, Australia

  5. 5

    The Children's Hospital at Westmead, Cochrane Renal Group, Centre for Kidney Research, Westmead, NSW, Australia

  6. 6

    Consorzio Mario Negri Sud, Unit of Biostatistics, Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Italy

  7. 7

    IRCCS "Casa Sollievo della Sofferenza", Unit of Biostatistics, San Giovanni Rotondo (FG), Chieti, Italy

  8. 8

    Concord Repatriation General Hospital, Department of Renal Medicine, Concord, NSW, Australia

  9. 9

    The University of Sydney at Westmead, Centre for Transplant and Renal Research, Westmead Millennium Institute, Westmead, NSW, Australia

  10. 10

    Monash University, School of Public Health and Preventive Medicine, Monash Applied Research Stream, Clayton, VIC, Australia

  11. 11

    University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy

  12. 12

    Mario Negri Sud Consortium, Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Italy

  13. 13

    Diaverum, Medical-Scientific Office, Lund, Sweden

*Suetonia C Palmer, Department of Medicine, University of Otago Christchurch, 2 Riccarton Ave, PO Box 4345, Christchurch, 8140, New Zealand. suetonia.palmer@otago.ac.nz.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 30 APR 2013

SEARCH

  1. You have free access to this content

    Current Version

    Antiplatelet agents for chronic kidney disease

    Suetonia C Palmer, Lucia Di Micco, Mona Razavian, Jonathan C Craig, Vlado Perkovic, Fabio Pellegrini, Meg J Jardine, Angela C Webster, Sophia Zoungas and Giovanni FM Strippoli

    Article first published online: 30 APR 2013 | DOI: 10.1002/14651858.CD008834.pub3

Previous versions of this article and their online publication dates

  1. You have free access to this content

    Version 2

    Antiplatelet agents for chronic kidney disease

    Suetonia C Palmer, Lucia Di Micco, Mona Razavian, Jonathan C Craig, Vlado Perkovic, Fabio Pellegrini, Meg J Jardine, Angela C Webster, Sophia Zoungas and Giovanni FM Strippoli

    Article first published online: 28 FEB 2013 | DOI: 10.1002/14651858.CD008834.pub2

  2. Version 1

    Antiplatelet agents for chronic kidney disease

    Mona Razavian, Lucia Di Micco, Suetonia C Palmer, Jonathan C Craig, Vlado Perkovic, Sophia Zoungas, Angela C Webster, Meg J Jardine and Giovanni FM Strippoli

    Article first published online: 10 NOV 2010 | DOI: 10.1002/14651858.CD008834